1. Home
  2. CTSO vs BEAT Comparison

CTSO vs BEAT Comparison

Compare CTSO & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.39

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.50

Market Cap

27.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
BEAT
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
27.7M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
CTSO
BEAT
Price
$0.39
$0.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.38
$5.63
AVG Volume (30 Days)
58.7K
424.2K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
15.07
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.35
$0.48
52 Week High
$1.19
$4.00

Technical Indicators

Market Signals
Indicator
CTSO
BEAT
Relative Strength Index (RSI) 52.89 39.82
Support Level $0.36 $0.49
Resistance Level $0.40 $0.79
Average True Range (ATR) 0.03 0.04
MACD 0.00 0.01
Stochastic Oscillator 80.00 10.78

Price Performance

Historical Comparison
CTSO
BEAT

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: